Sputnik Light

AXP000171.1 · Vaccine

Platform
human adenovirus 26 (non-replicating)
Targets
SARS-CoV-2 S
Originator
Gamaleya Research Institute of Epidemiology and Microbiology
Sponsor
Gamaleya Research Institute of Epidemiology and Microbiology

Names

NameTypeSource
Sputnik Lightpreferred name, brandcurator, wikidata
Gam-COVID-Vac component I ambiguoussynonymwikidata

Virus

Role
Vaccine vector
Family
Adenoviridae
Virus
human adenovirus 26
Strain
rAd26
Replication
non replicating
Modifications
single non-replicating rAd26 dose encoding the full-length SARS-CoV-2 spike
Transgenes
SARS-CoV-2 spike
Route
intramuscular
Source
evidence

Approvals

AgencyRegionDateStatusBrandIndicationSource
otherRU2021-05-06conditionalSputnik LightSingle-dose prevention of COVID-19source

Clinical trials (2)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT04741061Study to Evaluate Efficacy, Immunogenicity and Safety of the Sputnik-LightUnknownPhase 32021-02-192021-12-316000COVID-19 Prevention
NCT04713488An Open Study on the Safety, Tolerability, and Immunogenicity of "Sputnik Light" VaccineUnknownPhase 1/22021-01-152021-07-20110COVID-19 Prevention

Recent changes

No changes recorded in its trials yet.

Clinical papers

No confirmed clinical papers yet.

Other papers

Preclinical studies, reviews and other papers that name it.

PubMedTitleJournalYearLinked by
PMID 40264579The Parameters of Long-Term Humoral Immunity Induced by a Single Injection of the Sputnik Light Vaccine Among Noninfected Volunteers and Those Infected with SARS-CoV-2.Acta naturae2025name in title: Sputnik Light
PMID 38282667Assessing the prevalence and patterns of COVID-19 vaccine side effects among Syrian adults: A cross-sectional study.Preventive medicine reports2024name in abstract: Sputnik Light
PMID 38413637Exploring the reported adverse effects of COVID-19 vaccines among vaccinated Arab populations: a multi-national survey study.Scientific reports2024name in abstract: Sputnik Light
PMID 38543960Comparative Analysis of SARS-CoV-2 Antibody Responses across Global and Lesser-Studied Vaccines.Vaccines2024name in abstract: Sputnik Light
PMID 39100722COVID-19 Vaccines Breakthrough Infections and Adverse Effects Reported by the Birzeit University Community in Palestine.International journal of general medicine2024name in abstract: Sputnik Light
PMID 39772064Receptor Binding Domain-Specific B Cell Memory Responses Among Individuals Vaccinated Against SARS-CoV-2.Vaccines2024name in abstract: Sputnik Light
PMID 37919737The impact of geo-political socio-economic factors on vaccine dissemination trends: a case-study on COVID-19 vaccination strategies.BMC public health2023name in abstract: Sputnik Light
PMID 35101893Boosting of the SARS-CoV-2-Specific Immune Response after Vaccination with Single-Dose Sputnik Light Vaccine.Journal of immunology (Baltimore, Md. : 1950)2022name in title: Sputnik Light
PMID 35751563Comparison of the immunogenicity of five COVID-19 vaccines in Sri Lanka.Immunology2022name in abstract: Sputnik Light
PMID 35943061Immunity after COVID-19 vaccination in people with higher risk of compromised immune status: a scoping review.The Cochrane database of systematic reviews2022name in abstract: Sputnik Light
PMID 36138385COVID-19 vaccines effectiveness against symptomatic SARS-CoV-2 during Delta variant surge: a preliminary assessment from a case-control study in St. Petersburg, Russia.BMC public health2022name in abstract: Sputnik Light
PMID 36366311Sputnik Light and Sputnik V Vaccination Is Effective at Protecting Medical Personnel from COVID-19 during the Period of Delta Variant Dominance.Vaccines2022name in title: Sputnik Light
PMID 34746910An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine "Sputnik Light" for prevention of coronavirus infection in healthy adults.The Lancet regional health. Europe2021name in title: Sputnik Light
PMID 35146337Review of COVID-19 viral vector-based vaccines and COVID-19 variants.Le infezioni in medicina2021name in abstract: Sputnik Light

Notes

The first (rAd26) component of Gam-COVID-Vac alone, authorised in Russia as a separate single-dose product on 6 May 2021. Kept apart from AXP000170 because it is registered and marketed as its own product, but it is the same construct as that regimen's first dose: a candidate for merging if the registry decides route/regimen variants should not be split.

How to cite

Sputnik Light (AXP000171.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000171.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.